Allyson Egan

420 total citations
16 papers, 114 citations indexed

About

Allyson Egan is a scholar working on Rheumatology, Pulmonary and Respiratory Medicine and Surgery. According to data from OpenAlex, Allyson Egan has authored 16 papers receiving a total of 114 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Rheumatology, 9 papers in Pulmonary and Respiratory Medicine and 7 papers in Surgery. Recurrent topics in Allyson Egan's work include Vasculitis and related conditions (9 papers), Eosinophilic Disorders and Syndromes (6 papers) and Eosinophilic Esophagitis (4 papers). Allyson Egan is often cited by papers focused on Vasculitis and related conditions (9 papers), Eosinophilic Disorders and Syndromes (6 papers) and Eosinophilic Esophagitis (4 papers). Allyson Egan collaborates with scholars based in United Kingdom, Spain and United States. Allyson Egan's co-authors include David Jayne, Andreas Kronbichler, Hans‐Joachim Anders, Peter Johnston, David J. Lomas, P.D. Britton, Gail Jamieson, P. Farman, Stephen Revell and Richard Coulden and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Autoimmunity Reviews.

In The Last Decade

Allyson Egan

12 papers receiving 110 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Allyson Egan United Kingdom 5 46 42 38 33 17 16 114
L. Pérard France 4 22 0.5× 74 1.8× 48 1.3× 59 1.8× 10 0.6× 22 192
Ricardo Cubedo Cervera Spain 5 37 0.8× 80 1.9× 19 0.5× 15 0.5× 30 1.8× 5 145
Aurélia Lanteri France 4 16 0.3× 71 1.7× 9 0.2× 18 0.5× 16 0.9× 5 114
Cláudia Ferrão Portugal 5 28 0.6× 115 2.7× 28 0.7× 6 0.2× 26 1.5× 6 170
Katsutoshi Kuriyama Japan 4 138 3.0× 52 1.2× 68 1.8× 14 0.4× 19 1.1× 15 169
Shingo Watanabe Japan 7 71 1.5× 14 0.3× 164 4.3× 37 1.1× 12 0.7× 28 275
Joseph Rivalan France 8 38 0.8× 16 0.4× 58 1.5× 8 0.2× 28 1.6× 13 222
Giovanni Cagnotto Sweden 4 15 0.3× 76 1.8× 7 0.2× 10 0.3× 30 1.8× 12 130
Biljana Brezina United Kingdom 4 9 0.2× 85 2.0× 17 0.4× 13 0.4× 55 3.2× 7 143
Alejandro Repiso Spain 7 64 1.4× 8 0.2× 55 1.4× 9 0.3× 7 0.4× 23 113

Countries citing papers authored by Allyson Egan

Since Specialization
Citations

This map shows the geographic impact of Allyson Egan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Allyson Egan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Allyson Egan more than expected).

Fields of papers citing papers by Allyson Egan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Allyson Egan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Allyson Egan. The network helps show where Allyson Egan may publish in the future.

Co-authorship network of co-authors of Allyson Egan

This figure shows the co-authorship network connecting the top 25 collaborators of Allyson Egan. A scholar is included among the top collaborators of Allyson Egan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Allyson Egan. Allyson Egan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Specks, Ulrich, Michael E. Wechsler, David J. Jackson, et al.. (2024). Safety of Benralizumab in the Treatment of Eosinophilic Granulomatosis With Polyangiitis During the Open-label Extension Period of the Phase 3 MANDARA Study. A5358–A5358. 1 indexed citations
2.
Hollick, Rosemary, Avril Nicoll, Louise Locock, et al.. (2024). Identifying key health system components associated with improved outcomes to inform the re-configuration of services for adults with rare autoimmune rheumatic diseases: a mixed-methods study. The Lancet Rheumatology. 6(6). e361–e373. 6 indexed citations
3.
Bettiol, Alessandra, Vincent Cottin, Allyson Egan, et al.. (2024). POS0337 MEPOLIZUMAB VERSUS BENRALIZUMAB FOR EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS (EGPA): A EUROPEAN REAL-LIFE RETROSPECTIVE COMPARATIVE STUDY. Annals of the Rheumatic Diseases. 83. 390–391. 2 indexed citations
4.
Xipell, Marc, Gema M. Lledó, Allyson Egan, et al.. (2023). From systemic lupus erythematosus to lupus nephritis: The evolving road to targeted therapies. Autoimmunity Reviews. 22(10). 103404–103404. 27 indexed citations
5.
Bond, Milena, Filippo Fagni, Michéle Moretti, et al.. (2022). At the Heart of Eosinophilic Granulomatosis with Polyangiitis: into Cardiac and Vascular Involvement. Current Rheumatology Reports. 24(11). 337–351. 13 indexed citations
6.
Egan, Allyson, Rona Smith, & David Jayne. (2021). Introduction to the European Vasculitis Society 3rd International Vasculitis Course (Cambridge) case-based supplement. Lara D. Veeken. 60(Supplement_3). iii1–iii5.
7.
Gopaluni, Seerapani, Allyson Egan, Marc Xipell, & David Jayne. (2021). Refractory ANCA-associated vasculitis. Lara D. Veeken. 60(Supplement_3). iii63–iii66. 1 indexed citations
8.
Mescia, Federica, Allyson Egan, Kim Cheema, Pasupathy Sivasothy, & David Jayne. (2021). Eosinophilic granulomatosis with polyangiitis present and future. Lara D. Veeken. 60(Supplement_3). iii24–iii27.
9.
Egan, Allyson, James E. Peters, Elaine C. Jolly, et al.. (2021). A critical beat in eosinophilic granulomatosis with polyangiitis. Lara D. Veeken. 60(Supplement_3). iii28–iii31. 1 indexed citations
10.
Smith, Rona, et al.. (2021). Cardiac decompensation revealing giant cell arteritis. Lara D. Veeken. 60(Supplement_3). iii9–iii11.
11.
Kronbichler, Andreas, Duvuru Geetha, Rona Smith, et al.. (2021). The COVID-19 pandemic and ANCA-associated vasculitis – reports from the EUVAS meeting and EUVAS education forum. Autoimmunity Reviews. 20(12). 102986–102986. 24 indexed citations
12.
Xipell, Marc, Allyson Egan, Gema M. Lledó, et al.. (2021). Understanding tubulointerstitial injury and repair mechanisms paves the way for renal outcome improvement in lupus nephritis. Revista Colombiana de Reumatología. 28. 82–89. 2 indexed citations
13.
Sánchez‐Sendra, Beatriz, Allyson Egan, David Jayne, Lisa Willcocks, & Rachel Jones. (2019). 296. PLASMA EXCHANGE AS A NOVEL TREATMENT FOR IGA VASCULITIS WITH NEPHRITIS. Lara D. Veeken. 58(Supplement_2).
14.
Egan, Allyson, Milena Bond, & David Jayne. (2019). 295. CARDIOVASCULAR DISEASE IN EOSINOPHILIC GRANULOMATOSIS WITH POLYANGIITIS. Lara D. Veeken. 58(Supplement_2). 1 indexed citations
15.
Egan, Allyson, Tarun Sabharwal, Brock E. Harper, et al.. (2005). Endocarditis and ulnar artery aneurysm as presenting features of antiphospholipid syndrome and polyarteritis nodosa. Lupus. 14(11). 914–917. 4 indexed citations
16.
Lomas, David J., P.D. Britton, P. Farman, et al.. (1992). Duplex doppler ultrasound for the detection of vascular occlusion following liver transplantation in children. Clinical Radiology. 46(1). 38–42. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by L. Pérard Breakdown of academic impact, for papers by Ricardo Cubedo Cervera Breakdown of academic impact, for papers by Aurélia Lanteri Breakdown of academic impact, for papers by Cláudia Ferrão Breakdown of academic impact, for papers by Katsutoshi Kuriyama Breakdown of academic impact, for papers by Shingo Watanabe Breakdown of academic impact, for papers by Joseph Rivalan Breakdown of academic impact, for papers by Giovanni Cagnotto Breakdown of academic impact, for papers by Biljana Brezina Breakdown of academic impact, for papers by Alejandro Repiso
Rankless by CCL
2026